Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus

British Journal of Ophthalmology

Volumn 88, Issue 5, 2004, Pages 667-672

  Probst, K ^a   Fijnheer, R ^a   Schellekens, P ^a   Rothova, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; FIBRONECTIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RETINA MACULA EDEMA; UVEITIS; VITREOUS BODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; EYE; FEMALE; FIBRONECTINS; HUMANS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; UVEITIS; VITREOUS BODY;

EID: 1942485974     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.026542     Document Type: Article

References (45)

1. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 1999;97:239-49.
2. Tessler H, Lam S. Cystoid macular edema. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St Louis: Mosby: 553-9.
3. Bresnick GH. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 1983;90:1301-17.
4. Vinores S, Amin A, Derevjanik NL, et al. Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular oedema. Histochem J 1994;26:655-65.
5. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV Diabetic macular edema. Ophthalmology 1984;91:1464-74.
6. Bresnick GH. Diabetic macular edema. A review. Ophthalmology 1986;93:989-97.
7. Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 1999;97:297-309.
8. Rothova A, Suttorp-van Schulten MSA, Treffers WF, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-6.
9. Varano M, Scassa C, Ripandelli G, et al. New diagnostic tools for macular edema. Doc Ophthalmol 1999;97:373-9.
10. Smith RT, Lee CM, Charles HC, et al. Quantification of diabetic macular edema. Arch Ophthalmol 1987;105:218-22.
11. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134-9.
12. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-29.
13. Hynes RO. Fibronectins. Sci Am 1986;254:42-51.
14. Hynes RO. Molecular biology of fibronectin. Annu Rev Cell Biol 1985;1:67-90.
15. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375-413.
16. Magnusson MK, Mosher DF. Fibronectin. Structure, assembly and cardiovascular implications. Arterioscler Tromb Vasc Biol 1998;18:1363-70.
17. Peters JH, Ginsberg MH, Bohl BP, et al. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung. J Clin Invest 1986;78:1596-603.
18. Peters JH, Ginsberg MH, Case Cm, et al. Release of soluble fibronectine containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo. Am Rev Resp Dis 1988;138:167-74.
19. Clark R, Quinn J, Winn H, et al. Fibronectin is produced by blood vessels in response to injury. J Exp Med 1982;156:646-51.
20. Hiscott P, Waller HA, Grierson I, et al. The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes. Eye 1993;7:288-92.
21. Oshato M, Shiga S, Hitoshi K, et al. Immunohistochemical study of cellular fibronectin in preretinal membranes. Retina 1994;14:430-4.
22. Campochiaro P, Jerdan J, Glaser B. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci 1986;27:1615-21.
23. Hiscott P, Waller HA, Grierson I, et al. Local production of fibronectin by ectopic human retinal cells. Cell Tissue Res 1992;267:185-92.
24. Peters JH, Maunder RJ, Woolf AD, et al. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med 1989;113:586-97.
25. Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990;162:358-62.
26. Kanters SDJM, Banga JD, Algra A, et al. Plasma levels of cellular fibronectin in diabetes. Diabetes Care 2001;24:323-7.
27. Lelij van der A, Rothova A. Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 1997;81:976-9.
28. Murray P, Hoekzema R, Luyendijk L, et al. Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting. Invest Ophthalmol Vis Sci 1990;31:2129-35.
29. Boer de J, Verhagen C, Bruinenberg M, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 1996;121:650-8.
30. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996;44:1469-79.
31. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 1996;37:258-66.
32. Ni M, Chan CC, Nussenblatt RB, et al. Iris inflammatory cells, fibronectin, fibrinogen, and immunoglobulin in various ocular diseases. Arch Ophthalmol 1988;106:392-5.
33. Fujikawa LS, Chan CC, McAllister C, et al. Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. Cell Immunol 1987;106:139-50.
34. Wang J, Lin WL, Essner E, et al. Ultrastructural and immunocytochemical studies of iris vessels in rats with experimental autoimmune uveoretinitis. Curr Eye Res 1994;13:747-54.
35. Dunker S, Kleinert R, Faulborn J. lmmunhistologische Untersuchungen des Glasskörpers. Ophthalmologe 1998;95:8-12.
36. Vesaluomo M, Mertaniemi P, Mannonen S, et al. Cellular and plasma fibronectin in the aqueous humour of primary open-angle glaucoma, exfoliate glaucoma and cataract patients. Eye 1998;12:886-90.
37. Barlati S, Marchina E, Quaranta CA, et al. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair. Exp Eye Res 1990;51:1-9.
38. Kenarova B, Voinov L, Apostolov C, et al. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Eur J Ophthalmol 1997;7:64-7.
39. Casaroli Marano RP, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:2791-803.
40. Grisanti S, Heimann, Wiedemann P. Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy. Br J Ophthalmol 1993;77:238-42.
41. Kornblihtt A, Pesce C, Alonso C, et al. The fibronectin gene as a model for splicing and transcription studies. FASEB J 1996;10:248-57.
42. Sobel R, Mitchell M. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989;135:161-8.
43. Clark R, Dvorak H, Colvin R. Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. J Immunol 1981;126:787-93.
44. Kamei M, Kawasaki A, Tano Y. Analysis of extracellular matrix synthesis during wound healing of retinal pigment epithelial cells. Microsc Res Tech 1998;42:311-16.
45. Stocks SZ, Shiels IA, Taylor SM. Homologous serum-stimulated fibronectin synthesis in human retinal pigmented epithelial cells. Aust NZ J Ophthalmol 1999;27:247-9.